Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Inhibrx Biosciences, Inc. shareholders approved Election of the following nominees as Class II directors of the Company at the 2026-06-03 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-03
Exact text from the filing
Proposal 1 Election of the following nominees as Class II directors of the Company, nominated by the Company’s Board of Directors (the “Board of Directors”), each to serve until the 2029 Annual Meeting of Stockholders and until their respective successor is duly elected and qualified, or until their respective earlier death, resignation, or removal. Votes For Votes Withheld Broker Non-Votes Douglas G. Forsyth 7,608,469 1,463,474 2,469,289 Kimberly Manhard 9,035,097 36,846 2,469,289
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Inhibrx Biosciences, Inc. shareholders approved Ratification of the appointment by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-03 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-03
Exact text from the filing
Proposal 2 Ratification of the appointment by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Votes Abstained 11,510,478 30,347 407
View on SEC.gov